BioPort 2018, Atlantic Canada’s largest health and life sciences industry conference, explored trends transforming the industry in Halifax, November 7 & 8, 2018.
This year’s conference focused on The Future of Health, with sessions covering the impact of new technology on health and the value of the emerging medical cannabis market.
The annual Conference, hosted by our friends at BioNova, attracts health and life sciences innovators, industry leaders, and investors from across North America.
Picomole from Moncton, New Brunswick was named the winner of this year’s BioInnovation Challenge. Picomole is an innovative medical technology company with the goal of developing their patented and patent-pending technologies for breath analytics into the standard of care for non-invasive clinical diagnostics and personalized medicine.
Stephen Graham of Picomole told us: “This experience has been invaluable. The mentorship and training we’ve received through this process has helped take Picomole to the next level, and we know the funding and the advisory services will help to elevate us even more.”
Picomole will receive a prize package that includes $25,000 in seed funding and an advisory services package worth more than $30,000. Picomole was up against Matthew Kay, CEO of TalemHealth Analytics and Gabrielle Masone, CEO of Coloursmith Labs.
New to this year’s program was BIC Junior, a pitch competition for students that aims to cultivate the next generation of health and life sciences innovators. Emergence director, Martin Yuill, was a judge for the BIC Junior pitch competition.
This year’s conference featured two keynote speakers. Dr. Corinna Lathan, ranked as one of the ‘Top 100 World Innovators’ by MIT Technology Review, delivered the evening keynote on the impact of technology on health.